Akero Therapeutics Inc.

42.66
-0.92 (-2.11%)
At close: Mar 28, 2025, 3:59 PM
42.53
-0.30%
After-hours: Mar 28, 2025, 07:55 PM EDT

Akero Therapeutics Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
Cash & Equivalents 340.24M 234.21M 249.77M 150.48M 187.24M 136.4M 75.97M 598K
Short-Term Investments 402.84M 315.8M 101.68M 37.77M 81.14M 71.61M n/a n/a
Long-Term Investments n/a 19.28M n/a n/a 40K 40K 20K 20K
Other Long-Term Assets 54.75M n/a 108K 417K 161K 29K n/a n/a
Receivables n/a n/a n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 27.3M 9.95M 7.45M 10.65M 5.92M 3.3M 2.31M 80K
Total Current Assets 770.38M 559.96M 355.17M 193.58M 271.35M 138.05M 77.13M 638K
Property-Plant & Equipment 755K 1.03M 1.29M 1.55M 1.79M n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 55.51M 20.31M 1.4M 1.97M 1.99M 69K 20K 20K
Total Assets 825.89M 580.27M 356.57M 195.55M 273.34M 138.12M 77.15M 658K
Account Payables 9.03M 7.04M 7.97M 6.71M 3.43M 947K 1.37M 60K
Deferred Revenue n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt 631K 522K 325K 205K 294K 85K n/a n/a
Other Current Liabilities 30.1M 11.57M 10.79M 18.22M 9.39M 8.34M 969K 162K
Total Current Liabilities 39.75M 19.13M 19.08M 25.13M 13.11M 9.37M 2.34M 222K
Long-Term Debt 1.06M 25.78M 10.62M 2.62M 3.03M n/a n/a n/a
Other Long-Term Liabilities 34.96M 54K 305K -1.31M -1.52M 23K 124.73M 5M
Total Long-Term Liabilities 36.02M 25.84M 10.93M 1.31M 1.52M 23K 124.73M 5M
Total Liabilities 75.77M 44.97M 30.01M 26.44M 14.63M 9.39M 127.07M 5.22M
Total Debt 529K 26.3M 10.95M 1.52M 1.81M n/a n/a n/a
Common Stock 7K 6K 5K 4K 4K 3K n/a n/a
Retained Earnings -826.16M -574.1M -422.34M -310.3M -209.53M -130.32M -86.56M -4.56M
Comprehensive Income 948K 270K 37K -27K -3K -6K n/a n/a
Shareholders Equity 750.11M 535.31M 326.56M 169.11M 258.71M 128.73M -49.92M -4.56M
Total Investments 402.84M 335.09M 101.68M 37.77M 81.14M 71.61M 20K 20K